Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_assertion type Assertion NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_head.
- NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_assertion description "[Primary melanoma in patients greater than 60 years old was characterized by the increased expression of miRs regulating TLR-MyD88-NF-kappaB pathway (hsa-miR-199a), RAS/RAB22A pathway (hsa-miR-204); growth differentiation and migration (hsa-miR337), epithelial mesenchymal transition (EMT) (let-7b, hsa-miR-10b/10b*), invasion and metastasis (hsa-miR-10b/10b*), hsa-miR-30a/e*, hsa-miR-29c*; cellular matrix components (hsa-miR-29c*); invasion-cytokinesis (hsa-miR-99b*) compared to melanoma of younger patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_provenance.
- NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_assertion evidence source_evidence_literature NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_provenance.
- NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_assertion SIO_000772 20302635 NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_provenance.
- NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_assertion wasDerivedFrom befree-2016 NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_provenance.
- NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_assertion wasGeneratedBy ECO_0000203 NP801078.RA_WMJegkTD30dWNMS_FAxXM7ONmG77wNjv42-gqe1wyE130_provenance.